Recruiting NA Hip Fractures

Compares treatment options for Hip Fractures

Official title PENG vs Femoral Block for Hip Fracture Analgesia

ClinicalTrials.gov ID: NCT07073209

What this study is testing

What is Bupivacaine , epinephrine Dexamethasone?

Bupivacaine , epinephrine Dexamethasone is an investigational medicine, given as a monthly pill taken by mouth, being studied as a potential treatment for hip fractures.

Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.

What it's testing
This study aims to compare the Pericapsular Nerve Group (PENG) block with femoral block for hip fracture pain. Participants presenting to the hospital with a diagnosis of hip fracture and consenting to analgesic block will receive either a PENG or femoral block.
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older

You may be able to join if

  • Male or female ≥ 18 years of age.
  • ASA Classification 1-4
  • Documentation of a hip fracture diagnosis along with radiologic read indicating fracture location
  • Written, informed consent for analgesic peripheral block placement

You likely can't join if

  • Altered mental status to the extent that it limits ability to report pain score
  • Patient or health care proxy refusal of analgesic nerve block
  • Allergy to study medications or contraindication to peripheral nerve block
  • Peri-prosthetic fracture
  • Any additional fractures in a patient with a unilateral hip fracture

The study team makes the final eligibility decision.

Where it's taking place

  • Manhattan, New York, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Manhattan, New York, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.